Orexo announces results confirming the clinical profile of OX17 in ... - Business Wire (press release) by Acid reflux disease symptoms

Mon, 05 May 2008 01:35:54 -0400

Orexo announces results confirming the clinical profile of OX17 in ... - Business Wire (press release)

by Acid reflux disease symptoms @ Mon, 05 May 2008 01:35:54 -0400

Orexo announces results confirming the clinical profile of OX17 in ...
Business Wire (press release), CA -Mar 27, 2008
GERD, gastroesofageal reflux disease, is a common ailment in the Western world. Orexos product OX17 combines the advantages (rapid onset and sustained ...